AstraZeneca has filed a patent suit against Pharmacor over its plans to list a generic version of AstraZeneca’s blockbuster diabetes drug Forxiga on the PBS, but will have to defend the validity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results